Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Chubb
UBS
Cerilliant
Merck
McKinsey
Novartis
Cipla
Citi
Colorcon

Generated: October 19, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021142

« Back to Dashboard
NDA 021142 describes OLUX, which is a drug marketed by Mylan Pharms Inc and is included in two NDAs. It is available from three suppliers. There are four patents protecting this drug and two Paragraph IV challenges. Additional details are available on the OLUX profile page.

The generic ingredient in OLUX is clobetasol propionate. There are thirteen drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.

Summary for NDA: 021142

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details

Pharmacology for NDA: 021142

Suppliers and Packaging for NDA: 021142

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
OLUX
clobetasol propionate
AEROSOL, FOAM;TOPICAL 021142 NDA Prestium Pharma, Inc. 40076-031 40076-031-00 100 g in 1 CAN (40076-031-00)
OLUX
clobetasol propionate
AEROSOL, FOAM;TOPICAL 021142 NDA Prestium Pharma, Inc. 40076-031 40076-031-50 50 g in 1 CAN (40076-031-50)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:AEROSOL, FOAM;TOPICALStrength0.05%
Approval Date:May 26, 2000TE:AB1RLD:Yes

Expired Orange Book Patents for NDA: 021142

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan Pharms Inc
OLUX
clobetasol propionate
AEROSOL, FOAM;TOPICAL021142-001May 26, 2000► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
US Department of Justice
Covington
Chinese Patent Office
Medtronic
Cerilliant
Queensland Health
Healthtrust
Accenture
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot